Lent Michelle R, Visek Meghan, Syracuse Paulina, Dugosh Karen L, Festinger David S
School of Professional and Applied Psychology, Philadelphia College of Osteopathic Medicine, 4190 City Avenue, Philadelphia, PA, 19131, USA.
Research & Evaluation Group, Public Health Management Corporation, 1500 Market Street, Philadelphia, PA, 19102, USA.
J Cannabis Res. 2022 Aug 27;4(1):48. doi: 10.1186/s42238-022-00157-6.
Few studies have evaluated weight change in patients who initiate medical marijuana treatment to address diagnosed health concerns. The objective of this study was to examine whether patients initiating medical marijuana use for a qualifying health condition experienced changes in health and biopsychosocial functioning over time, including weight gain or loss. Specifically, this observational, longitudinal study evaluated changes in the body mass index (BMI) of adults with co-morbid obesity (body mass index [BMI] ≥ 30 kg/m) and severe obesity (BMI ≥ 40 kg/m) who were starting medical marijuana treatment for any of the 23 qualifying medical conditions at one of three dispensaries in Pennsylvania. Height and weight measurements were collected at baseline (prior to medical marijuana use) and then 90 days (± 14 days) later. Participants included in analyses (n = 52, M = 55.0 ± 13.6 years, 59.6% female) had a mean baseline BMI of 36.2 ± 5.4 kg/m and the majority sought medical marijuana for chronic pain (73.1%). No significant change in BMI was observed from baseline to month three (p > 0.05) in the sample. Additionally, no significant change in BMI was observed in the subset of patients with severe obesity (n = 12, p > 0.05). Our findings are limited by low follow-up rates and convenience sampling methodology but may help to mitigate weight gain concerns in the context of medical marijuana use.
很少有研究评估过为解决已确诊的健康问题而开始使用医用大麻治疗的患者的体重变化。本研究的目的是检验因符合条件的健康状况而开始使用医用大麻的患者,其健康状况和生物心理社会功能随时间推移是否发生变化,包括体重增加或减轻。具体而言,这项观察性纵向研究评估了宾夕法尼亚州三家药房之一的患有合并症肥胖(体重指数[BMI]≥30kg/m²)和重度肥胖(BMI≥40kg/m²)的成年人,因23种符合条件的医疗状况中的任何一种开始使用医用大麻治疗时,其体重指数(BMI)的变化。在基线(开始使用医用大麻之前)以及90天(±14天)后收集身高和体重测量数据。纳入分析的参与者(n = 52,M = 55.0±13.6岁,59.6%为女性)的平均基线BMI为36.2±5.4kg/m²,大多数人寻求医用大麻治疗慢性疼痛(73.1%)。在样本中,从基线到第三个月未观察到BMI有显著变化(p>0.05)。此外,在重度肥胖患者亚组中(n = 12,p>0.05)也未观察到BMI有显著变化。我们的研究结果受到低随访率和便利抽样方法的限制,但可能有助于减轻在使用医用大麻背景下对体重增加的担忧。